TotalMarketCap

Lexicon Pharmaceuticals

LXRXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$723.053 M

$1.63 +9.80%

Close of 6 Nov 2026

As of 6 Nov 2026, Lexicon Pharmaceuticals (LXRX) has a market capitalization of $723.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$49.8M

#2717 by revenue

Earnings

-$50.3M

Loss-making

Shares outstanding

445,234,571

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #162AnnexonANNX$755.5M
  2. #163ArdelyxARDX$750.3M
  3. #164Lexicon PharmaceuticalsLXRX$723.1M
  4. #165Ironwood PharmaceuticalsIRWD$657.7M
  5. #166Sagimet BiosciencesSGMT$642.6M

What if Lexicon Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$63,459.93

Per share 39,052× higher

Bitcoin $1.53T

$3,433.71

Per share 2,113× higher

Apple $5.02T

$11,272.54

Per share 6,937× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Lexicon Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.